Stay updated on CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference11%
- Check23 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new version but no substantive content changes.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1; the Back to Top link was removed. No other core content, pricing, stock, or time-slot information appears to have changed.SummaryDifference0.6%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.6%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference32%
- Check66 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.